Agranulocytosis and Electrocardiogram qt prolonged

Summary:

Electrocardiogram qt prolonged is found among people with Agranulocytosis, especially for people who are female, 60+ old.

The study analyzes which people have Electrocardiogram qt prolonged with Agranulocytosis. It is created by eHealthMe based on reports of 32 people who have Agranulocytosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

What is Electrocardiogram qt prolonged?

Electrocardiogram qt prolonged is found to be associated with 1,394 drugs and 1,518 conditions by eHealthMe. Check the latest studies of Electrocardiogram qt prolonged.



On Jul, 16, 2026

32 people who have Agranulocytosis and Electrocardiogram Qt Prolonged are studied.

Would you have Electrocardiogram qt prolonged when you have Agranulocytosis?

Gender of people who have Agranulocytosis and experienced Electrocardiogram Qt Prolonged *:

  • female: 80 %
  • male: 20 %

Age of people who have Agranulocytosis and experienced Electrocardiogram Qt Prolonged *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 10.0 %
  • 40-49: 0.0 %
  • 50-59: 13.33 %
  • 60+: 76.67 %

Common co-existing conditions for these people *:

  1. Nausea (feeling of having an urge to vomit): 19 people, 59.38%
  2. Oedema Peripheral (superficial swelling): 14 people, 43.75%
  3. High Blood Pressure: 14 people, 43.75%
  4. Hypokalemia (low potassium): 14 people, 43.75%
  5. Stress And Anxiety: 13 people, 40.62%
  6. Diarrhea: 13 people, 40.62%
  7. Abdominal Pain: 13 people, 40.62%
  8. Ovarian Cancer (cancer of ovary): 13 people, 40.62%
  9. Rashes (redness): 13 people, 40.62%
  10. Anaemia (lack of blood): 9 people, 28.12%

Common drugs taken by these people *:

  1. Neupogen: 16 people, 50.00%
  2. Ondansetron: 14 people, 43.75%
  3. Xanax: 14 people, 43.75%
  4. Paracetamol: 13 people, 40.62%
  5. Morphine: 13 people, 40.62%
  6. Innohep: 13 people, 40.62%
  7. Imodium: 13 people, 40.62%
  8. Flagyl: 13 people, 40.62%
  9. Zyprexa: 13 people, 40.62%
  10. Cordarone: 13 people, 40.62%

Common symptoms for these people *:

  1. Thrombocytopenia (decrease of platelets in blood): 25 people, 78.12%
  2. Anaemia (lack of blood): 23 people, 71.88%
  3. Febrile Neutropenia (fever with reduced white blood cells): 23 people, 71.88%
  4. Fatigue (feeling of tiredness): 18 people, 56.25%
  5. Hypokalemia (low potassium): 16 people, 50.00%
  6. Nausea (feeling of having an urge to vomit): 14 people, 43.75%
  7. Stress And Anxiety: 14 people, 43.75%
  8. Abdominal Pain: 14 people, 43.75%
  9. Diarrhea: 13 people, 40.62%
  10. Depressed Mood: 13 people, 40.62%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Electrocardiogram qt prolonged?

- Check whether Electrocardiogram qt prolonged is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Electrocardiogram qt prolonged:

All the conditions that are associated with Electrocardiogram qt prolonged:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Electrocardiogram qt prolonged and Agranulocytosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: